During pregnancy cell-free fetal DNA is present in the plasma and serum of pregnant women. This fetal DNA can be sued for fetal genotyping, but can also provide indirect information about the course and outcome of a pregnancy. Florentine Thurik’s research investigates the use of this kind of fetal genotyping for the purposes of screening for hemolytic disease. She also looks at associations between levels of placental DNA and adverse pregnancy outcomes.
F.F. Thurik: Cell-Free Placental DNA beyond Down Syndrome. Lessons Learned from Fetal RHD Genotyping.
Prof. C.E. van der Schoot
Prof. A. Franx (UU)
Dr G.C.M.L. Page-Christiaens
This event is open to the public.